Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside (Record no. 3025970)

MARC details
000 -LEADER
fixed length control field 06176naaaa2201525uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/87543
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220714201349.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number books978-3-0365-4489-2
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783036544908
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783036544892
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3390/books978-3-0365-4489-2
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
072 #7 - SUBJECT CATEGORY CODE
Subject category code TB
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code TBX
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code TGM
Source bicssc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Tagit, Oya
Relator code edt
9 (RLIN) 1628618
245 10 - TITLE STATEMENT
Title Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Basel
Name of publisher, distributor, etc MDPI - Multidisciplinary Digital Publishing Institute
Date of publication, distribution, etc 2022
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (296 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc Nanomedicine is among the most promising emerging fields that can provide innovative and radical solutions to unmet needs in pharmaceutical formulation development. Encapsulation of active pharmaceutical ingredients within nano-size carriers offers several benefits, namely, protection of the therapeutic agents from degradation, their increased solubility and bioavailability, improved pharmacokinetics, reduced toxicity, enhanced therapeutic efficacy, decreased drug immunogenicity, targeted delivery, and simultaneous imaging and treatment options with a single system.Poly(lactide-co-glycolide) (PLGA) is one of the most commonly used polymers in nanomedicine formulations due to its excellent biocompatibility, tunable degradation characteristics, and high versatility. Furthermore, PLGA is approved by the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) for use in pharmaceutical products. Nanomedicines based on PLGA nanoparticles can offer tremendous opportunities in the diagnosis, monitoring, and treatment of various diseases.This Special Issue aims to focus on the bench-to-bedside development of PLGA nanoparticles including (but not limited to) design, development, physicochemical characterization, scale-up production, efficacy and safety assessment, and biodistribution studies of these nanomedicine formulations.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
-- https://creativecommons.org/licenses/by/4.0/
-- cc
-- https://creativecommons.org/licenses/by/4.0/
546 ## - LANGUAGE NOTE
Language note English
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Technology: general issues
Source of heading or term bicssc
9 (RLIN) 928609
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element History of engineering & technology
Source of heading or term bicssc
9 (RLIN) 1129967
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Materials science
Source of heading or term bicssc
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term poly(lactic-co-glycolic acid) (PLGA)
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term blood-brain barrier (BBB)
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term current Good Manufacturing Practice (cGMP)
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Food and Drug Administration (FDA)
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanotechnology
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term neurodegenerative diseases
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term drug delivery
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term central nervous system
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term neuroprotective drugs
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term fluorescent labeling
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term DiI
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term coumarin 6
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term rhodamine 123
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Cy5.5
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term quantum yield
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term brightness
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term stability of fluorescent label
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term confocal microscopy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term intracellular internalization
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term in vivo neuroimaging
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term double-emulsion method
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term dry powder inhalation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term antigen release
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term porous PLGA particles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microfluidics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term methotrexate
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term chitosan
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLA/PLGA
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term sustained release
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term micro-implant
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term animal model
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term minimally invasive
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term drug delivery system
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term poly (lactic-co-glycolic acid) (PLGA)
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microfluidic
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term pharmacokinetics (PK) and biodistribution
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term atorvastatin calcium
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term poly(lactide-co-glycolide)
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term polymeric nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term carrageenan induced inflammation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term anti-inflammatory
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term radiolabeled nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nuclear medicine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term photothermal therapy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term phthalocyanine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term SKOVip-kat
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Katushka
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term TurboFP635
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term JO-4
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term orthotopic tumors
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term 3D culture
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term spheroids
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term poly(lactic-co-glycolic acid)
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanomedicine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term scale-up manufacturing
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term clinical translation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term inline sonication
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tangential flow filtration
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term lyophilization
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term downstream processing
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term H. pylori
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term design of experiments
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term poly(lactic-co-glycolic) acid
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term size
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cancer
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term chemoimmunotherapy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immunogenic cell death
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immune checkpoint blockade
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PNA5 glycopeptide
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term mas receptor
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term angiotensin
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PLGA diblock copolymer
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term ester and acid-end capped
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term double emulsion solvent evaporation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term biocompatible
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term biodegradable
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cardiovascular
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanoparticle
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term solid-state characterization
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term in vitro
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term drug release kinetics modeling
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term PEGylation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term amine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term emulsion
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term polyvinyl alcohol (PVA)
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Pluronic triblock copolymer
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term trehalose
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term sucrose
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Indomethacin
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term solvents
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term stabilizers
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term morphology
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term particle-size
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term encapsulation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term drug release
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cytotoxicity
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tagit, Oya
Relator code oth
9 (RLIN) 1628618
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/5741">https://mdpi.com/books/pdfview/book/5741</a>
-- 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/87543">https://directory.doabooks.org/handle/20.500.12854/87543</a>
-- 0
Public note DOAB: description of the publication
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        E-Books Open Access OPJGU Sonepat- Campus OPJGU Sonepat- Campus 14/07/2022   14/07/2022 14/07/2022 Electronic-Books

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library